吸烟与颅内动脉瘤:意大利人群中CYP2A6基因单核苷酸多态性的初步分析
在单一机构招募331例意大利散发性颅内动脉瘤患者及150名健康对照,分析CYP2A6 ∗1B2、∗2、∗14单核苷酸多态性与动脉瘤及吸烟的关系。当前吸烟者动脉瘤性蛛网膜下腔出血频率显著更高(P<0.001;OR=17.45);携带杂合CYP2A6 ∗1B2等位基因者动脉瘤破裂与吸烟相关(P<0.001;OR=15.47)。
要点
- 当前吸烟者动脉瘤性蛛网膜下腔出血频率显著更高(P<0.001;OR=17.45),与CYP2A6单核苷酸多态性模式无关。
- 携带杂合CYP2A6 ∗1B2等位基因的患者中,动脉瘤破裂与吸烟相关(P<0.001;OR=15.47)。
- 携带杂合CYP2A6 ∗14等位基因的患者均发生动脉瘤性蛛网膜下腔出血(100%),但该关联无统计学显著性(P=1)。
核心结论
- 携带完全活性CYP2A6酶(杂合∗1B2等位基因)的吸烟者相比功能较低活性变异者可能有更高的颅内动脉瘤破裂风险,需在更大样本中进一步研究验证。
- 杂合CYP2A6 ∗14等位基因在动脉瘤性蛛网膜下腔出血中的作用尚待阐明。
研究设计与样本
- 在单一机构招募331例意大利散发性颅内动脉瘤患者,并纳入150名健康对照。
- 记录临床起病是否伴蛛网膜下腔出血及吸烟习惯。
- 采用标准程序对外周血样本进行基因分析,检测CYP2A6 ∗1B2、CYP2A6 ∗2和CYP2A6 ∗14单核苷酸多态性。
- 统计分析按照遗传关联研究指南进行。
主要发现
- 患者队列中,当前吸烟者的动脉瘤性蛛网膜下腔出血频率显著更高(P<0.001;OR=17.45),与CYP2A6单核苷酸多态性模式无关。
- 携带杂合CYP2A6 ∗1B2等位基因的患者中,动脉瘤破裂与吸烟相关(P<0.001;OR=15.47)。
- 所有携带杂合CYP2A6 ∗14等位基因的患者均发生动脉瘤性蛛网膜下腔出血(100%),与吸烟习惯无关,但该关联无统计学显著性(P=1)。
关键数值与推荐
- 当前吸烟者动脉瘤性蛛网膜下腔出血频率显著更高(P<0.001;OR=17.45),与CYP2A6单核苷酸多态性模式无关。
- 携带杂合CYP2A6 ∗1B2等位基因的患者中,动脉瘤破裂与吸烟相关(P<0.001;OR=15.47)。
- 携带杂合CYP2A6 ∗14等位基因的患者均发生动脉瘤性蛛网膜下腔出血(100%),但该关联无统计学显著性(P=1)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出需在更大样本中进一步研究以验证结果。
- 原文结论指出杂合CYP2A6 ∗14等位基因在动脉瘤性蛛网膜下腔出血中的作用尚待阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cigarette smoking is a modifiable risk factor associated with formation and rupture of intracranial aneurysms (IAs). Cytochrome P450 2A6 (CYP2A6) is the main enzyme implied in catabolism of nicotine and xenobiotics, giving rise to oxidative stress products. Our study investigated the associations between specific single-nucleotide polymorphisms (SNPs) in the CYP2A6 gene and the presence of sporadic IAs in a cluster of Italian patients, as well as their rupture regarding cigarette smoking habit. METHODS: Three hundred and thirty-one Italian patients with sporadic IAs were recruited in a single institution. We recorded data on clinical onset with subarachnoid hemorrhage (SAH) and smoking habit. Genetic analysis was performed with a standard procedure on peripheral blood samples: CYP2A6 ∗1B2, CYP2A6 ∗2, and CYP2A6 ∗14 SNPs were analyzed in the study group along with 150 healthy control subjects. Statistical analysis was conducted according to genetic association study guidelines. RESULTS: In the patient cohort, the frequency of aSAH was significantly higher in current smokers (P < 0.001; OR=17.45), regardless of the pattern of CYP2A6 SNPs. There was a correlation between IA rupture and cigarette smoking in patients with the heterozygous CYP2A6 ∗1B2 allele (P < 0.001; OR=15.47). All patients carrying the heterozygous CYP2A6 ∗14 allele had an aSAH event (100%), regardless of smoking habit, although this correlation was not statistically significant (P = 1). CONCLUSIONS: According to our findings, a cigarette smoker carrying a fully active CYP2A6 enzyme (heterozygous ∗1B2 allele) may have an increased risk of IA rupture compared to those with functionally less active variants: further investigation on a larger sample is needed to verify this result. The role of the heterozygous CYP2A6 ∗14 allele in aSAH is yet to be clarified.
引用
- Ferrari E, Cornali C, Fiorindi A, et al. Cigarette Smoking and Intracranial Aneurysms: A Pilot Analysis of SNPs in the CYP2A6 Gene in the Italian Population. World Neurosurg. 2023. PMID: 37689358. doi:10.1016/j.wneu.2023.08.128
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。